Symptomatic patients, according to daily electronic diary data between visit 2 (Day -8) and Visit 3 (Day 1), with a total score of 1 or more on at least 4 of the last 7 days prior to visit 3
You may not be if
Patients who have had a COPD exacerbation requiring systemic corticosteroids and/or antibiotics and/or hospitalization in the 6 weeks prior to the first visit
Patients who have had a respiratory tract infection within 4 weeks prior to the first visit
Patients with concomitant pulmonary disease
Patients with diabetes Type I or uncontrolled diabetes Type II
Any patient with lung cancer or a history of lung cancer
Patients with a history of certain cardiovascular co-morbid conditions
Patients with a history of asthma or a blood eosinophil count \>600/mm3 or onset of symptoms prior to 40 years
Patients with eczema, known high IgE levels or a known positive skin prick test
Patients participating in the active phase of a pulmonary rehabilitation programme
Patients contraindicated for the treatment with anticholinergics, long and short-acting beta-2 agonists or sympathomimetic amines
Patients with a history of alpha-1 anti-trypsin deficiency
Patients on long term oxygen therapy (\>15hr per day)
Clareo Health | Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
